Apotea (APOTEA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Apotea (APOTEA) has a cash flow conversion efficiency ratio of 0.120x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr112.50 Million ≈ $12.11 Million USD) by net assets (Skr940.60 Million ≈ $101.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Apotea - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how Apotea's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Apotea debt and liabilities for a breakdown of total debt and financial obligations.
Apotea Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Apotea ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hebei Huijin Electromechanical Co Ltd
SHE:300368
|
-0.047x |
|
WUS Printed Circuit Co Ltd
TW:2316
|
-0.028x |
|
Celebi Hava Servisi AS
IS:CLEBI
|
-0.086x |
|
Akums Drugs and Pharmaceutical
NSE:AKUMS
|
N/A |
|
Bain Capital Specialty Finance Inc
NYSE:BCSF
|
0.024x |
|
Shanghai Baosteel Packaging
SHG:601968
|
0.070x |
|
Neo Performance Materials Inc
TO:NEO
|
-0.077x |
|
Double Bond Chemical Ind Co Ltd
TW:4764
|
0.030x |
Annual Cash Flow Conversion Efficiency for Apotea (2022–2025)
The table below shows the annual cash flow conversion efficiency of Apotea from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Apotea.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr859.90 Million ≈ $92.54 Million |
Skr333.30 Million ≈ $35.87 Million |
0.388x | +19.55% |
| 2024-12-31 | Skr636.00 Million ≈ $68.44 Million |
Skr206.20 Million ≈ $22.19 Million |
0.324x | -36.15% |
| 2023-12-31 | Skr425.00 Million ≈ $45.74 Million |
Skr215.80 Million ≈ $23.22 Million |
0.508x | +472.24% |
| 2022-12-31 | Skr355.00 Million ≈ $38.20 Million |
Skr31.50 Million ≈ $3.39 Million |
0.089x | -- |
About Apotea
Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and dr… Read more